A major clinical trial just gave cannabis the strongest pain research it's ever had — 820 people, 12 months, published in one of the world's top medical journals. Here's what it actually found, and why it doesn't mean what most headlines made it sound like.

A new 2026 study looked at whether CBG — a lesser-known cannabinoid — could affect the immune cells that drive rheumatoid arthritis. The results were more specific than most cannabis research. Here's what it actually found, and what it doesn't mean for you yet.